Cargando…
Dosage amplification dictates oncogenic regulation by the NKX2-1 lineage factor in lung adenocarcinoma
Amplified oncogene expression is a critical and widespread driver event in cancer, yet our understanding of how amplification-mediated elevated dosage mediates oncogenic regulation is limited. Here, we find that the most significant focal amplification event in lung adenocarcinoma (LUAD) targets a l...
Autores principales: | Pulice, John L., Meyerson, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664179/ https://www.ncbi.nlm.nih.gov/pubmed/37994369 http://dx.doi.org/10.1101/2023.10.26.563996 |
Ejemplares similares
-
Suppression of Lung Adenocarcinoma Progression by Nkx2-1
por: Winslow, Monte M., et al.
Publicado: (2011) -
Oncogenic RIT1 mutations in lung adenocarcinoma
por: Berger, A H, et al.
Publicado: (2014) -
MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas
por: Luan, Zhou, et al.
Publicado: (2021) -
Receptor tyrosine kinase‐like orphan receptor 1, a target of NKX2‐1/TTF‐1 lineage‐survival oncogene, inhibits apoptosis signal‐regulating kinase 1‐mediated pro‐apoptotic signaling in lung adenocarcinoma
por: Ida, Lisa, et al.
Publicado: (2016) -
Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis
por: Zhao, Xiangyu, et al.
Publicado: (2022)